INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 150 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,488,139 | -39.2% | 205,191 | -21.6% | 0.23% | -29.8% |
Q2 2023 | $10,678,855 | +10.5% | 261,865 | +1.0% | 0.33% | +11.9% |
Q1 2023 | $9,663,515 | +27.3% | 259,284 | +19.1% | 0.29% | +26.7% |
Q4 2022 | $7,592,866 | -10.0% | 217,623 | +44.3% | 0.23% | -15.9% |
Q3 2022 | $8,441,000 | -0.8% | 150,835 | -8.2% | 0.28% | -4.8% |
Q2 2022 | $8,506,000 | +26.4% | 164,345 | +77.5% | 0.29% | +73.7% |
Q1 2022 | $6,730,000 | -50.8% | 92,609 | -20.0% | 0.17% | -40.8% |
Q4 2021 | $13,690,000 | -45.4% | 115,783 | -38.1% | 0.28% | -40.8% |
Q3 2021 | $25,084,000 | -31.4% | 186,985 | -17.2% | 0.48% | -30.1% |
Q2 2021 | $36,560,000 | +117.6% | 225,803 | +7.8% | 0.68% | +91.3% |
Q1 2021 | $16,805,000 | +152.9% | 209,389 | +71.4% | 0.36% | +138.9% |
Q4 2020 | $6,645,000 | +351.4% | 122,143 | +65.0% | 0.15% | +198.0% |
Q3 2020 | $1,472,000 | -8.2% | 74,034 | -3.0% | 0.05% | -13.8% |
Q2 2020 | $1,604,000 | +120.9% | 76,305 | +28.6% | 0.06% | +48.7% |
Q1 2020 | $726,000 | -17.7% | 59,342 | -1.3% | 0.04% | -4.9% |
Q4 2019 | $882,000 | +10.7% | 60,107 | +0.7% | 0.04% | -6.8% |
Q3 2019 | $797,000 | -11.7% | 59,691 | +8.2% | 0.04% | -2.2% |
Q2 2019 | $903,000 | -6.8% | 55,163 | -2.8% | 0.04% | -13.5% |
Q1 2019 | $969,000 | +16.7% | 56,760 | -6.7% | 0.05% | -11.9% |
Q4 2018 | $830,000 | -64.8% | 60,834 | -26.1% | 0.06% | -53.9% |
Q3 2018 | $2,357,000 | -28.6% | 82,359 | -31.7% | 0.13% | -35.7% |
Q2 2018 | $3,301,000 | +41.7% | 120,645 | +9.2% | 0.20% | +18.5% |
Q1 2018 | $2,329,000 | -7.2% | 110,442 | -15.4% | 0.17% | -14.7% |
Q4 2017 | $2,510,000 | -64.7% | 130,608 | -54.4% | 0.20% | -66.8% |
Q3 2017 | $7,111,000 | +66.2% | 286,144 | +7.0% | 0.59% | +50.5% |
Q2 2017 | $4,278,000 | – | 267,360 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |